000 | 01934 a2200589 4500 | ||
---|---|---|---|
005 | 20250515054706.0 | ||
264 | 0 | _c20070725 | |
008 | 200707s 0 0 eng d | ||
022 | _a0960-894X | ||
024 | 7 |
_a10.1016/j.bmcl.2007.01.005 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMadsen-Duggan, Christina B | |
245 | 0 | 0 |
_aLead optimization of 5,6-diarylpyridines as CB1 receptor inverse agonists. _h[electronic resource] |
260 |
_bBioorganic & medicinal chemistry letters _cApr 2007 |
||
300 |
_a2031-5 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
650 | 0 | 4 |
_aChemistry, Pharmaceutical _xmethods |
650 | 0 | 4 | _aDrug Design |
650 | 0 | 4 |
_aFeeding Behavior _xdrug effects |
650 | 0 | 4 | _aInhibitory Concentration 50 |
650 | 0 | 4 | _aModels, Chemical |
650 | 0 | 4 | _aMolecular Conformation |
650 | 0 | 4 |
_aPyridines _xchemical synthesis |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptor, Cannabinoid, CB1 _xagonists |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 | _aTemperature |
650 | 0 | 4 |
_aToluene _xchemistry |
700 | 1 | _aDebenham, John S | |
700 | 1 | _aWalsh, Thomas F | |
700 | 1 | _aToupence, Richard B | |
700 | 1 | _aHuang, Song X | |
700 | 1 | _aWang, Junying | |
700 | 1 | _aTong, Xinchun | |
700 | 1 | _aLao, Julie | |
700 | 1 | _aFong, Tung M | |
700 | 1 | _aSchaeffer, Marie-Therese | |
700 | 1 | _aXiao, Jing Chen | |
700 | 1 | _aHuang, Cathy R-R C | |
700 | 1 | _aShen, Chun-Pyn | |
700 | 1 | _aStribling, D Sloan | |
700 | 1 | _aShearman, Lauren P | |
700 | 1 | _aStrack, Alison M | |
700 | 1 | _aMacIntyre, D Euan | |
700 | 1 | _aVan der Ploeg, Lex H T | |
700 | 1 | _aGoulet, Mark T | |
773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 17 _gno. 7 _gp. 2031-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmcl.2007.01.005 _zAvailable from publisher's website |
999 |
_c16831371 _d16831371 |